ArgusEye Makes It On ’33-Listan’ for the Third Time – Achieves ‘Gold Company’ Status
For the third consecutive year, ArgusEye has secured [...]
ArgusEye closes €2.8 million funding to accelerate bioprocessing
Today we’re announcing an oversubscribed funding round of [...]
ArgusEye introduces AugaOne™ to accelerate downstream bioprocess development
• AugaOne™ sensor system provides specific, real-time, and automated [...]
The Countdown Begins: Just Two Months Until the Exciting Launch of AugaOne™!
With the product launch swiftly approaching, ArgusEye offers an [...]
ArgusEye – Among the Top 33 Tech Startups in Sweden, Once Again!
For the second consecutive year, ArgusEye proudly secures its place [...]
ArgusEye signs agreement with Optronic for intensified product development and increased manufacturing capacity
ArgusEye has recently entered into a strategic collaboration agreement [...]
ArgusEye – one of Sweden’s top Startups 2022
ArgusEye has been listed in the prestigious 33-listan by [...]
ArgusEye closes deal with the downstream group within biological development at Bayer AG
The multinational pharmaceutical and biotechnology company, Bayer AG, has [...]
Another successful week for ArgusEye during TESTA Challenge 2022
During March 14 – April 1, ArgusEye participated in [...]
ArgusEye selected for TESTA Challenge 2022
ArgusEye has again been selected to participate in TESTA [...]